Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients

Conclusions Among older patients with AF and CAD, overall warfarin use was low. Patients ≥80 years old at highest stroke risk received warfarin in similar proportions to the overall cohort. Further investigation into optimizing antithrombotic strategies in this population is warranted.
Source: American Heart Journal - Category: Cardiology Source Type: research